A Step Ahead Towards
Better Health
  Support
Login
Newsletter
Subscription
SEDOTER
 LAUNCH

Sedoter Launch

SEDICO Pharmaceuticals has launched Sedoter tablets (Tolterodine 1 mg & 2 mg tablets) which is the first anti-muscarinic drug for Over-Active Bladder (OAB) released by SEDICO company.

The launch was honored by the presence of Dr. Ihab Kaldas (SEDICO CCO) who has the opening speech, Prof. Dr. Azzam Mahran (Medical Department  Manager), Dr.Ashraf Hamdy (Marketing manager), Dr.Hesham Shoukry (National sales manager) & the Scientific office managers all over the country.

SEDICO celebrating the launch at Novotel Airport Hotel - Cairo at the presence of CH team of the Scientific Office.

"SEDOTER LAUNCH"  

 Date: 24 & 25 April ,2017
Venue: Novotel Airport , Cairo , Egypt

Launch Photos Gallery

Doctors Speakers

Sedoter 1 mg tablets
Dr. Ihab Kaldas
(SEDICO CCO)
"Opening"

Prof. Dr. Azzam Mahran
(SEDICO Medical Dept. Manager)
"Medical Knowledge on Anti-muscarinic & Tolterodine"

Dr. Ashraf Hamdy
 (Marketing Manager)
 "Marketing Review"

Dr. Hesham Shoukry
(Scientific Office Manager)
"Sales Review"

Dr. Ashraf Hamdy
 (Marketing Manager)
 "Product Knowledge & Marketing plan
of Sedoter"
Sedoter 2 mg tablets

 

  Home Online Order Useful Links Site Map Privacy Policy  

© 2004 SEDICO Co. All rights reserved

Designed & Developed by EBM Co.